HOOK HOOKIPA Pharma, Inc.: Market Value
The HOOKIPA Pharma Inc. (HOOK) price chart demonstrates the dynamics of a company implementing software robots for vaccine data analysis and automating molecule screening. The current metric stands at 0.01. Management, possessing an impeccable reputation, is optimizing expenses through collaborations with industry behemoths. Furthermore, management is betting on the creation of viral vectors to combat cancer, attracting external investment through strategic alliances.
Comprehensive metric breakdowns and analytics for hookipapharma.com (HOOK)
- market price and analyst price targets:
- company stock capitalization data:
- book value of equity indicators:
- debt and liquidity data:
Total Debt to Capital HOOKIPA Pharma Inc.|HOOK - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital HOOKIPA Pharma|HOOK - Company Aggregate Debts|Debt to Book Capitalization Ratio HOOKIPA Pharma Inc.|HOOK - Company Long-Term Loans and Borrowings|Company Short-Term Debt HOOKIPA Pharma|Quick Ratio hookipapharma.com
- business earnings and investment ratios data:
HOOK - Net Profit|Future Profit HOOKIPA Pharma Inc.|HOOK - Company Value to Net Income|Forward P/E Multiple HOOKIPA Pharma|HOOK - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HOOKIPA Pharma Inc.|HOOK - Operating profit before deduction of amortization|Earnings per share for the last twelve months HOOKIPA Pharma|HOOK - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months hookipapharma.com|HOOK - Earnings growth in current year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc.
Fundamental company analysis:HOOK (HOOKIPA)
The assessment of the financial stability of HOOKIPA Pharma Inc. (HOOK) begins with an analysis of the aggregate value of all outstanding shares. This indicator measures the market value of the business, allowing short-term noise to be separated from long-term institutional trends. The dynamics of the company's market capitalization reflect investor confidence in the scale of the enterprise. This capitalization confirms the firm's ability to maintain a complex cold chain during the delivery of immunotherapeutic agents, ensuring the safe transportation of oncology drugs.
Key competitors
Market Value argenx ARGX|BioNTech Inc. (BNTX) - Market Value|ABVX - Market Value|Market Value ADMA Corp|Protagonist Therapeutics (PTGX) - Market Value|immunovant.com (IMVT) - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|Market Value JBIO (Aerovate Therapeutics Inc)|Aclaris Therapeutics (ACRS) - Market Value|Market Value kyvernatx.com (KYTX)|Market Value Tiziana Life Sciences Ltd|Market Value Cabaletta Bio Inc. CABA|Market Value Ventyx Bio (VTYX)|Market Capitalization Theratechnologies, Inc (THTX)|Market Capitalization AVTX (Avalo Therapeutics, Inc)|Market Capitalization eledon.com (ELDN)|AGEN - Market Value|Market Valuation CLYM|ZURA: Market Capitalization|aTyr Pharmaceuticals (ATYR) - Market Capitalization|Market Valuation ADAG|IMA: Market Value|Market Value Shattuck Labs, Inc. (STTK)|EQ: Market Valuation|Market Capitalization CNTB (Connect Biopharma Holdings Limited)|Market Value IMUX|Atara Biotherapeutics Inc - Market Capitalization|IFRX - Market Capitalization|X4 Pharmaceuticals, Inc. (XFOR) - Market Value|Adicet Bio, Inc. - Market Value|Market Value Celularity Inc|Market Valuation INmune Bio Corporation (INMB)|Market Capitalization BRNS|Market Capitalization kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Market Valuation|Market Value AKTX|Enlivex Therapeutics, Ltd. - Market Capitalization|Market Capitalization Q32 Bio Inc. QTTB|GeoVax Labs, Inc. (GOVX) - Market Value|Market Capitalization EDSA|IBIO (iBio) - Market Capitalization|Market Valuation Carisma Tx (CARM)|Market Valuation XTLB (XTL Biopharmaceuticals, Ltd.)|Market Capitalization boltbio.com|Market Capitalization HCWB (HCW Biologics)|Market Value APVO|AIM - Market Value|Market Value Aditxt|GRI Bio Corp (GRI) - Market Value|Market Value XORTX Corp (XRTX)|Market Value Vyome Holdings Inc|Market Capitalization revbiosciences.com|Market Value Indaptus Therapeutics, Inc. (INDP)|SCNI: Market Valuation|Market Capitalization CALI (CalciMedica)|Market Value AFMD|Allakos Therapeutics - Market Capitalization|IGMS - Market Capitalization|iTeos Therapeutics, Inc. (ITOS) - Market Value|Ocean Biomedical Inc - Market Value|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
